SCHEMBL9825201

SCHEMBL9825201

COC1=NOC(CN(C(=O)OCc2ccccc2)C(=O)[C@@H](N)[C@@H](C)O)C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 6/20 0.36
ITGA2B P08514 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ABCB1 P08183 1/20 0.34
SLC15A1 P46059 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
TGM2 P21980 1/20 0.34
ITGAV P06756 4/20 0.33
CYP2C19 P33261 1/20 0.33
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CCR5 P51681 1/20 0.33
IARS1 P41252 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9825695 0.92 IARS1 (0.40) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL9826384 0.89 TGM2 (0.37) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL9825095 0.89 TGM2 (0.37) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL4598577 0.89 TGM2 (0.44) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL9825868 0.88 L3MBTL1 (0.36) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL9826162 0.84 ITGB3 (0.37) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A
SCHEMBL9825400 0.83 L3MBTL1 (0.33) ITGB3ITGA2BCYP2C19MEN1KMT2A
SCHEMBL4598860 0.80 TGM2 (0.42) ITGB3ITGA2BSMN1; SMN2SLC15A1TGM2
SCHEMBL9826306 0.80 TACR1 (0.45) TGM2MEN1KMT2A
SCHEMBL9825800 0.80 IARS1 (0.37) ITGB3ITGA2BSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0237082-B1 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1991-05-29 EP disclosed
US-4929630-A SKIN DISORDERS, ACNE, 4,5-DIHYDROISOOXAZOLE PEPTIDES SYNTEX (U.S.A.) INC. (US) 1990-05-29 US disclosed
US-4912120-A Containing amine and amide substitution SYNTEX (U.S.A.) INC. (US) 1990-03-27 US disclosed
EP-0237082-A2 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors SYNTEX (U.S.A.) INC. (US) 1987-09-16 EP disclosed